Wikidata

(Q42288163)

English

A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents

scientific article published on April 2013

In more languages

Statements

title
A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
23114369
retrieved
19 October 2017
author name string
Helen S Marshall
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
23114369
retrieved
19 October 2017
Peter C Richmond
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
23114369
retrieved
19 October 2017
Qin Jiang
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
23114369
retrieved
19 October 2017
Shannon L Harris
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
23114369
retrieved
19 October 2017
Thomas R Jones
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
23114369
retrieved
19 October 2017
John L Perez
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
23114369
retrieved
19 October 2017
publication date
1 April 2013
1 reference
stated in
Europe PubMed Central
PubMed ID
23114369
retrieved
19 October 2017
page(s)
364-371
1 reference
stated in
Europe PubMed Central
PubMed ID
23114369
retrieved
19 October 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q42288163&oldid=1941297514"